论文部分内容阅读
武汉健民药业(集团)股份有限公司是国家重点中成药基地和小儿用药生产中心,其前身系建于明朝崇祯年间的“叶开泰”药店,迄今已有360年历史。为使企业在激烈的市场竞争中,永葆勃勃生机,焕发新的光采,他们在广泛开展市场调查的基础上,运用市场细分原理,对产品进行了重新定位,拟定出该集团以拳头产品为契机进行市场开发的营销计划。一、市场环境与营销状况武汉健民药业(集团)有限股份公司共生产14大剂型190余种产品,以生产小儿用药及出口产品为其特色,不少产品荣获国优、部优、省优及市优。该公司的拳头产品龙牡壮骨冲剂,是国家一级中药保护品种,被列为国家医药局
Wuhan Jianmin Pharmaceutical (Group) Co., Ltd. is a national key proprietary Chinese medicine base and pediatric drug production center. Its predecessor was the Yekaitai pharmacy built during the Chongzhen period in the Ming Dynasty, and it has a history of 360 years. In order to enable companies to survive and thrive in the fierce market competition, they launched a new brilliance. Based on extensive market research, they used market segmentation principles to reposition their products and formulate the group’s fists. Product as a marketing plan for market development. I. Market Environment and Marketing Status Wuhan Jianmin Pharmaceutical (Group) Co., Ltd. has produced more than 190 kinds of products with 14 major dosage forms. It is characterized by the production of pediatric medicines and export products, and many products have won national, departmental, and provincial awards. Excellent and excellent city. The company’s fist product, Longmu Zhuanggu Granule, is a state-level Chinese traditional medicine protection product and is listed as the State Pharmaceutical Administration.